Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of hematological patients requiring emergency chemotherapy in the intensive care unit.
Lafarge A, Chean D, Whiting L, Clere-Jehl R; Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH); Clinical Research in Intensive Care and Sepsis - TRIal Group for Global Evaluation and Research in SEPsis (CRICS-TRIGGERSEP). Lafarge A, et al. Intensive Care Med. 2024 Jun;50(6):849-860. doi: 10.1007/s00134-024-07454-z. Epub 2024 May 15. Intensive Care Med. 2024. PMID: 38748265 Free PMC article. Review.
Corrigendum to: Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group.
Lafarge A, Joseph A, Pagnoux C, Puéchal X, Cohen P, Samson M, Hamidou M, Karras A, Quemeneur T, Ribi C, Groh M, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG). Lafarge A, et al. Rheumatology (Oxford). 2020 Sep 1;59(9):2653. doi: 10.1093/rheumatology/kez688. Rheumatology (Oxford). 2020. PMID: 31971593 No abstract available.
Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group.
Lafarge A, Joseph A, Pagnoux C, Puéchal X, Cohen P, Samson M, Hamidou M, Karras A, Quemeneur T, Ribi C, Groh M, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG). Lafarge A, et al. Rheumatology (Oxford). 2020 Sep 1;59(9):2250-2257. doi: 10.1093/rheumatology/kez575. Rheumatology (Oxford). 2020. PMID: 31782786
Risk of malignancy in patients treated for systemic necrotising vasculitis.
Lafarge A, Joseph A, Pagnoux C, Puechal X, Cohen P, Samson M, Hamidou M, Karras A, Groh M, Quemeneur T, Ribi C, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG). Lafarge A, et al. Ann Rheum Dis. 2020 Mar;79(3):431-433. doi: 10.1136/annrheumdis-2019-216452. Epub 2019 Nov 25. Ann Rheum Dis. 2020. PMID: 31767700 No abstract available.
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer.
Juncheng P, Joseph A, Lafarge A, Martins I, Obrist F, Pol J, Saavedra E, Li S, Sauvat A, Cerrato G, Lévesque S, Leduc M, Kepp O, Durand S, Aprahamian F, Nirmalathansan N, Michels J, Kroemer G, Castedo M. Juncheng P, et al. Among authors: lafarge a. J Immunother Cancer. 2022 Jun;10(6):e004280. doi: 10.1136/jitc-2021-004280. J Immunother Cancer. 2022. PMID: 35772809 Free PMC article.
Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU).
Anthon CT, Pène F, Perner A, Azoulay E, Puxty K, Van De Louw A, Barratt-Due A, Chawla S, Castro P, Póvoa P, Coelho L, Metaxa V, Kochanek M, Liebregts T, Kander T, Hästbacka J, Andreasen JB, Péju E, Nielsen LB, Hvas CL, Dufranc E, Canet E, Lundqvist L, Wright CJ, Schmidt J, Uhel F, Ait-Oufella H, Krag M, Cos Badia E, Díaz-Lagares C, Menat S, Voiriot G, Clausen NE, Lorentzen K, Kvåle R, Hildebrandt T, Holten AR, Strand K, Tzalavras A, Bestle MH, Klepstad P, Fernandez S, Vimpere D, Paulino C, Graça C, Lueck C, Juhl CS, Costa C, Bådstøløkken PM, Miranda T, Lêdo LSA, Sousa Torres JC, Granholm A, Møller MH, Russell L; on behalf of the PLOT-ICU Collaborators and the Nine-I Study Group. Anthon CT, et al. Intensive Care Med. 2023 Nov;49(11):1327-1338. doi: 10.1007/s00134-023-07225-2. Epub 2023 Oct 9. Intensive Care Med. 2023. PMID: 37812225 Free PMC article.
Severe infections requiring intensive care unit admission in patients receiving ibrutinib for hematological malignancies: a groupe de recherche respiratoire en réanimation onco-hématologique (GRRR-OH) study.
Baucher L, Lemiale V, Joseph A, Wallet F, Pineton de Chambrun M, Ferré A, Lombardi R, Platon L, Contejean A, Fuseau C, Calvet L, Pène F, Kouatchet A, Mokart D, Azoulay E, Lafarge A. Baucher L, et al. Among authors: lafarge a. Ann Intensive Care. 2023 Dec 6;13(1):123. doi: 10.1186/s13613-023-01219-5. Ann Intensive Care. 2023. PMID: 38055081 Free PMC article.
Severe Community-Acquired Pneumonia in Immunocompromised Patients.
Chean D, Windsor C, Lafarge A, Dupont T, Nakaa S, Whiting L, Joseph A, Lemiale V, Azoulay E. Chean D, et al. Among authors: lafarge a. Semin Respir Crit Care Med. 2024 Apr;45(2):255-265. doi: 10.1055/s-0043-1778137. Epub 2024 Jan 24. Semin Respir Crit Care Med. 2024. PMID: 38266998 Review.
41 results